Our joint health solution, FruiteX-B, is available for commercial use in the European Union (EU) through FutureCeuticals’ EU distributor, vaneeghen.

Achieving novel food status in the EU makes FruiteX-B more accessible to companies looking for safe and effective joint health ingredients.

To learn more, read the full press release.

We are honored and thrilled to announce that CognatiQ® has been selected as the 2023 Nutrition Industry Executive (NIE) New Ingredient Awards Winner in the Condition Specific category!

Congratulations to our team, who has worked very hard on this standout ingredient – and thank you to the judges and NIE for your consideration!

The industry continues to recognize CognatiQ as an outstanding product in the cognitive function category. To learn more about what makes it unique, visit our cognatiQ page futureceuticals.com/cognatiq.

Read more about why the judges selected CognatiQ® on page 52 of NIE’s October/November publication.

We’re thrilled to announce that CognatiQ® has been selected as the Ingredient of the Year in the Cognitive Function category of the 2023 NutraIngredients-USA Awards! Thank you to the judges and to NutraIngredients-USA for this honor!

This is a very special achievement for a very special ingredient! Learn more about what makes CognatiQ® unique at: futureceuticals.com/cognatiq

You can read more about why the judges selected CognatiQ® and the rest of this year’s winners in the NutraIngredients-USA Awards Brochure.